Report Details:
15 Companies Covered
163 Pages
The Growing Preference for Natural Remedies will positively impact the Global Herbal Medicine Market at a CAGR of 13.32% during the forecast period 2025 to 2035.
Market Research Future (MRFR) has published a cooked research report on the “Global Herbal Medicine Market” that contains information from 2019 to 2035. The Herbal Medicine Market is estimated to register a CAGR of 13.32% during the forecast period of 2025 to 2035.
MRFR recognizes the following companies as the key players in the Global Herbal Medicine Market: Arkopharma, Bayer AG, BEOVITA, Hishimo Pharmaceuticals, Schaper & Brümmer, ZeinPharma Germany GmbH, Venus Pharma GmbH, Dasherb Corp., Arizona Natural Products, Blackmores, Himalaya Holdings Ltd., and Dr. Willmar Schwabe India Pvt. Ltd.
Market Highlights
The Global Herbal Medicine Market is expected to register a CAGR of 13.32% during the forecast period and is estimated to reach USD 396.18 billion by 2035. Increasing consumer awareness about the adverse effects of allopathic drugs on health has changed consumer preferences, thus shifting the market focus toward natural remedies. In addition, during the COVID-19 pandemic, customers searching for immunity boosters increased the demand for herbal medicines.
The increased convenience offered by e-commerce has been a major market growth facilitator, particularly in regions where retail infrastructures are underdeveloped. The increased focus on preventive health care, the wellness culture in society, and government initiatives aimed at herbal R&D are also contributing to market growth.
Dabur, Himalaya Wellness, and Blackmores are a few of the businesses that make investments in global market expansion and product innovation. Dabur, for instance, strengthened its position in the thriving herbal wellness industry with the 2024 purchase of Kapiva, a herbal supplement start-up. In Europe, Schwabe Pharma has been introducing new herbal cognitive health supplements, and in the US, Nature's Way established a partnership with Amazon to release an exclusive line of herbal immunity products.
Segment Analysis
The Global Herbal Medicine Market has been segmented based on Form, Category, Source, and Distribution Channel.
Based on Form, the Capsules & Tablets segment dominated the market due to increased prescriptions and ease of consumption.
Based on Category, Herbal Pharmaceuticals accounted for the largest share, owing to the aging population and growing awareness of herbal therapeutics.
Based on the Distribution Channel, the E-commerce segment generated the highest revenue due to rising digitalization and increased mobile internet access.
Based on the Source, the Whole Plants segment led the market as they are extensively used for various medicinal formulations.
Region Analysis
By Region, the Herbal Medicine Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The primary reason why North America led the market was the high consumer awareness, as well as the growing acceptance of natural healthcare products. High consumer awareness alongside the growing use of herbal constituents in the region's cosmetics and dietary supplements propelled Europe to the second top position. The Asia-Pacific region is expected to increase rapidly and continue to strengthen due to rising disposable incomes and digital awareness, as well as the traditional roots of herbal medicine in countries like China and India.
Key Findings of the Study
• The Global Herbal Medicine Market is expected to reach USD 396.18 billion by 2035, at a CAGR of 13.32% during the forecast period.
• Asia-Pacific accounted for the fastest-growing market.
• Based on Form, the Capsules & Tablets segment held the largest market share in 2024.
• Based on the Distribution Channel, the E-commerce segment generated the highest revenue.
• Key market players include Arkopharma, Bayer AG, BEOVITA, Hishimo Pharmaceuticals, Schaper & Brümmer, ZeinPharma Germany GmbH, Venus Pharma GmbH, Dasherb Corp., Arizona Natural Products, Blackmores, Himalaya Holdings Ltd., and Dr. Willmar Schwabe India Pvt. Ltd.